logo

Human Reproductive Technologies Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The market is segmented By Reproductive Technology (Infertility drugs, Contraceptive), By Gender and Geography.

Home Industry Reports Healthcare Human Reproductive Technologies Market - Growth, Trends, COVID-19 Impact, and Fo ...

Market Snapshot

Human Reproductive Technologies Market Size
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 2 %
Human Reproductive Technologies Market Key Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The global human reproductive technologies market is anticipated to grow with a CAGR of nearly 2% during the forecast period. Rising prevalence of infertility and delayed family planning is expected to trigger the market growth. As per the US Department of Health & Human Services, one out of 100 couples are facing problem in conceiving, leading to the adoption of reproductive technologies to treat infertility rate which is further triggering the market growth. Moreover, change in lifestyle such as delay in bearing the first child, use of contraceptive pills, increased alcohol consumption and smoking is leading to increasing infertility rates and is providing a significant boost to the market. Growing patient awareness regarding the available technologies for treating problems related to reproduction is projected to increase the adoption of human reproductive technologies. However, Limited Insurance Coverage may restrain the growth of the market.

Scope of the Report

As per the scope of the report, Human reproductive technologies involves all current and anticipated uses of technology in reproduction, including infertility treatments, contraceptives drugs and devices. These technologies deals with treating the infertility problems and conceiving.

By Reproductive Technology
Infertility Treatment
Drugs
Follitropin Alfa
Follitropin Beta
Menotropins
Others
Devices
Sperm Separation Devices
Sperm Analyzer Systems
Ovum Aspiration Pumps
Micromanipulator Systems
Others
Contraceptive
Drugs
Oral Contraceptives
Topical Contraceptives
Contraceptive Injectable
Devices
Condoms
IUD
Cervical Caps
Diaphragms
Others
By Gender
Male
Female
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Contraceptive Segment is Expected to Hold a Major Market Share in the Human Reproductive Technologies Market

A contraceptive segment is expected to hold the largest segment owing to oral drugs are the easiest way of contraception in the industry, easy availability of a wide range of products, high awareness about contraceptive drugs and devices and simple mode of administration are the key factors triggering the segment growth. Moreover, increasing incidences of the Sexually Transmitted Disease (STD), an increasing rate of unplanned pregnancies and a rise in government initiatives are also some of the factors propelling the contraceptive drugs and devices segment.

Human Reproductive Technologies Market Research

North America Represents the Largest Market and Asia-Pacific is Expected to Register Fastest Growth.

North America is at the forefront of growth in the market studied and is also an important revenue contributor in the global arena. Rise in infertility rates due to high obesity rates, the rising age of conceptions and changes in lifestyle are stimulating the growth of the region. As per the US Department of Health & Human Services, an estimated 10% of women (6.1 million) in the United States are unable to conceive. Moreover, easy access to quality healthcare and favorable reimbursement policies are projected to promote revenue growth in North America.

The Asia Pacific region is likely to post the fastest market throughout the forecast period. The highest population, increasing awareness about reproductive technologies, rapid adoption of western lifestyle has led to the adoptions of these reproductive technologies. In addition, increasing healthcare spending is expected to propel the market in the APAC region.

Human Reproductive Technologies Market Share

Competitive Landscape

The Human Reproductive Technologies Market is fragmented in terms of competition and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are CooperSurgical, Inc., Teva Pharmaceutical Industries, AbbVie Inc., Ferring B.V., Merck KGaA, Genea Limited, and Ivftech.

CooperSurgical, Teva Pharmaceutical Industries, AbbVie Inc., Ferring B.V, Merck KGaA

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Prevalence of Infertility

      2. 4.2.2 Delayed Family Planning

    3. 4.3 Market Restraints

      1. 4.3.1 Limited Insurance Coverage

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Reproductive Technology

      1. 5.1.1 Infertility Treatment

        1. 5.1.1.1 Drugs

          1. 5.1.1.1.1 Follitropin Alfa

          2. 5.1.1.1.2 Follitropin Beta

          3. 5.1.1.1.3 Menotropins

          4. 5.1.1.1.4 Others

        2. 5.1.1.2 Devices

          1. 5.1.1.2.1 Sperm Separation Devices

          2. 5.1.1.2.2 Sperm Analyzer Systems

          3. 5.1.1.2.3 Ovum Aspiration Pumps

          4. 5.1.1.2.4 Micromanipulator Systems

          5. 5.1.1.2.5 Others

      2. 5.1.2 Contraceptive

        1. 5.1.2.1 Drugs

          1. 5.1.2.1.1 Oral Contraceptives

          2. 5.1.2.1.2 Topical Contraceptives

          3. 5.1.2.1.3 Contraceptive Injectable

        2. 5.1.2.2 Devices

          1. 5.1.2.2.1 Condoms

          2. 5.1.2.2.2 IUD

          3. 5.1.2.2.3 Cervical Caps

          4. 5.1.2.2.4 Diaphragms

          5. 5.1.2.2.5 Others

    2. 5.2 By Gender

      1. 5.2.1 Male

      2. 5.2.2 Female

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 CooperSurgical, Inc.

      2. 6.1.2 Teva Pharmaceutical Industries

      3. 6.1.3 AbbVie Inc.

      4. 6.1.4 Ferring B.V.

      5. 6.1.5 Merck KGaA

      6. 6.1.6 Genea Limited

      7. 6.1.7 Ivftech

      8. 6.1.8 Bayer AG

      2. *List Not Exhaustive

  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The undefined market is studied from 2018 - 2026.

The undefined is growing at a CAGR of 2% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

CooperSurgical, Teva Pharmaceutical Industries, AbbVie Inc., Ferring B.V, Merck KGaA are the major companies operating in undefined.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!